It’s Tuesday at the 2018 JP Morgan Healthcare conference in San Francisco…
Each day of #JPM18 we’re doing a rolling blog post which we’re updating throughout the day with commentary and insights on the company presentations we’re covering.
While we’re not giving a blow-by-blow account, we will be commenting on noteworthy news, and what we learn about pharma/biotech corporate strategy going into 2018.
For those of you who like to catch up with the final summary of each day’s highlights, you can read our post and commentary around Day 1 here (Link).
We’ve also posted a new interview with the Syros CEO, Dr Nancy Simonian, as part of our ASH/JPM18 crossover series. Syros are presenting on Thursday but had data last month at both SABCS and ASH.